Viewing Study NCT04419558


Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2025-12-25 @ 9:56 PM
Study NCT ID: NCT04419558
Status: TERMINATED
Last Update Posted: 2024-08-12
First Post: 2020-06-03
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Sponsor: FibroGen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-09-30
Start Date Type: ACTUAL
Primary Completion Date: 2023-09-04
Primary Completion Date Type: ACTUAL
Completion Date: 2023-09-04
Completion Date Type: ACTUAL
First Submit Date: 2020-06-03
First Submit QC Date: None
Study First Post Date: 2020-06-05
Study First Post Date Type: ACTUAL
Results First Submit Date: 2024-06-26
Results First Submit QC Date: None
Results First Post Date: 2024-08-12
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-08
Last Update Post Date: 2024-08-12
Last Update Post Date Type: ACTUAL